Clinical decision support tools have become a mainstay in many hospitals, helping clinicians identify early signs of serious conditions, flag potential deterioration and minimize medical errors. But ...

Software management struggles that have pained enterprises for decades cause the same anguish to government agencies, and a bill making its way through the US House of Representatives to strengthen ...

Since becoming chief technology officer (CTO) of GitLab in 2024, Sabrina Farmer has been focused on harnessing artificial intelligence (AI) to help developers automate mundane tasks, enabling them to ...

All Remote - GitLab Inc. (NASDAQ: GTLB), the most comprehensive, intelligent DevSecOps platform, today announced it has been named a Leader in the 2025 Gartner Magic Quadrant for DevOps Platforms.

SAN FRANCISCO--(BUSINESS WIRE)--All Remote - GitLab Inc. (NASDAQ: GTLB), the most comprehensive, intelligent DevSecOps platform, today announced it has been named a Leader in the 2025 Gartner Magic ...

GitLab positioned first in 4 out of 6 use cases in the accompanying 2025 Critical Capabilities for DevOps Platforms report All Remote - GitLab Inc. (NASDAQ: GTLB), the most comprehensive, intelligent ...

Background: Clinical decision support (CDS) is one strategy to increase evidence-based practices by clinicians. Despite its potential, CDS tools have had mixed results and are often disliked by ...

GitLab was recognized for its execution and vision. SAN FRANCISCO--(BUSINESS WIRE)-- All Remote - GitLab Inc. (NASDAQ: GTLB), the most comprehensive, intelligent DevSecOps platform, today announced it ...

Wind River, an Aptiv company and global leader in delivering software for the intelligent edge, announced the completion of Mobis Development Studio, an integrated software development environment for ...

GitLab’s AI-native DevSecOps platform is driving strong customer adoption. The company is seeing strong financial momentum. Despite its many strengths, it trades at a very reasonable valuation. 10 ...

Gitlab expects revenue growth to slow down in the second quarter. Margins continue to improve, but it's still losing money on a GAAP basis. The valuation has gotten more affordable at a forward ...